#Cannabis
Companies Embrace Innovation and Expansion with New Products (OTC: $CSUI) (TSX:
$RIV.TO) (OTC: $CNPOF) (TSX: $ALEF.TO) (OTC: $ALEAF) (OTC: $HEMP)
Point
Roberts WA, Delta, BC – May 13, 2020 - Investorideas.com, a leading
investor news resource covering hemp and cannabis stocks releases a special
news report on how the cannabis industry continues to expand and innovate
during the pandemic, featuring Cannabis Suisse Corp. (OTC:CSUI).
Cannabis
companies being deemed “essential” during the COVID-19 Pandemic, in addition to
booming online sales, has resulted in renewed vitality to an industry coming
off of an unstable year. Companies are not only looking at ways to better serve
communities and customers safely, but are also launching new products and using
this downtime for R & D and license expansion.
A
great example of this, Cannabis Suisse
Corp. (OTC:CSUI) just announced the addition of a
new retail product to its variety of offerings. They range from helping
consumers grow their own cannabis plants to a revolutionary, pure base CBD vape
liquid. During the global crisis, the Company is not ceasing to create and
deliver innovative ideas.
From the news: “Since the cannabis industry has
developed, the brands on the market have been working extensively on improving
the production quantity and the quality of pre-rolled joints. They have become
so popular among users of recreational cannabis due to their small size and
compactness. It’s a rather easy-to-use product that delivers an enjoyable and
unique experience anytime people use it.
The
simplicity of the joints is simply royal, which is no surprise due to Cannabis
Suisse Corp. partnering up with RAW, who are known for their ‘best of the best’
rolling papers. RAW comes unbleached, it contains neither chalk, nor dyes, nor
flammable additives. These papers just immerse smokers into the experience of
using the finest strains of V1 cannabis. Wrapped in unrefined natural paper,
the joints give customers a unique smoking experience with a gourmet taste.
The
V1 is special for its ability to relax users without sedation and to relieve
them without intoxication. The V1 strain is an immensely powerful CBD plant and
is guaranteed to contain no less than 20% CBD along with no more than 0.85%
THC. It is delicious to smoke having a natural hint of lemon and lime flavors
and an enjoyable fresh aftertaste.
The
V1 strains are derived from recreational strains and are one of the
best-selling products on the market. Over the last few years the V1 has surely
become one of the most exciting CBD strains containing around 90% Sativa and
10% Indica. The V1 plant is known to have low yield however it is widely used
for therapeutic purposes. People who tried consuming it in different ways
report having a feeling of peace and relaxation. It is easy to recognize by
hard compact flowerheads. Apart from the crystal appearance, the V1 also has a
strong specific scent. V1 will be the
main strain for ALPINE CANNABIS CBD tobacco production.
Cannabis
users from California, Colorado, Arizona, Oregon, and Washington spent around
$36 million in pre-rolled joints only in May of 2019 according to the report
introduced by BDS Analytics. (https://bdsa.com/wp-content/uploads/2019/07/CPI-Template-May.pdf). Apart from that,
in the end of 2019 the Swiss government finally removed the 25% tobacco tax
which was a significant event for the country. In five years from now, Europe
is expected to become the largest legal cannabis market in the world. In 2019,
the industry there has grown more than in the last six years together.
As
always, CSUI’s pre-rolled CBD joints are wrapped in premium quality paper from
RAW. They will be made only of quality fresh buds (no leaves, of course)
cultivated with non-pesticide fertilizers and biological control agents. The
new product line of handmade pre-rolled CBD joints will have no additives. They
are free from pesticides, fungicides, heavy metals or nicotine. Natural hemp is
always manually harvested and selected with care. No post-harvest wash
processing of the cannabis applies. The final product contains all the natural
terroir it is supposed to have. This is the Cannabis Suisse finest
ready-to-smoke weed product ever cultivated using proprietary growing methods
in fully contained facilities in Zurich, Switzerland.
Cannabis
Suisse is the first company in Switzerland to offer this uniquely blended
fusion of organic cones with optimally boosted CBD content. The THC level has
been naturally kept under 1%. CBD flower pre-rolled joints are an all-natural
alternative to CBD oil products. They offer pain- relieving, calming and
anti-inflammatory properties.
Any
cannabis consumer knows how difficult it is to choose a pre-rolled joint. There
are lots of doubts whether a package has really as much cannabis flower as the
manufacturer indicated, how joints will be wrapped and glued, how they will
smolder. Alpine Cannabis buyers will never encounter such problems. The company
maintains its work at a high-quality standard. The trademark gives consumers
100% confidence they will get premium quality goods. The quality of the
pre-rolled joints is not going to be different from the quality of cannabis
buds in bags where consumers can make sure what they are buying. Moreover, upon
trying and realizing the convenience of the joints, consumers will return for
them over and over again.
Each
step of creation process is taken by masters. The Company is happy to present
the highest quality and best priced CBD flower pre-rolled joints for the Swiss
retail market. The V1 strain is currently growing and the first retail supplies
of this product are expected to be ready for selected vendors in July 2020.
CSUI
has forward-looking plans to expand outside Switzerland developing customized
products. Some European countries like Germany, Denmark, Malta, Greece and
Italy discussed the possibility of creating a completely regulated cannabis
market by 2028. Furthermore, Luxembourg intends to introduce a regulated market
for adult use of cannabis by 2023.
Based on all of the
above advantages of the Company’s product, the situation in the European market
and forthcoming amendments to the legislation, the Company’s decision to launch
a new product line is more than an appropriate and timely one. An investment in
this production will pay off for the company in the nearest future, increase
the income and make the brand recognizable. In our forecasts, to get a minimum
of 400,000 CHF 12 months after the start of sales. CSUI’s pre- rolled joints
will become another business card of the Company’s trademark. The product will
occupy this niche in the market, crowding out other similar products.”
Canopy Rivers Inc. (TSX:
RIV)
(OTC:
CNPOF)
is also looking to bring new innovative products to market having recently
announced
a C$2 million investment in Dynaleo Inc., an Edmonton-based company focused on
white-label manufacturing edible cannabis gummies for the Canadian market.
Through this investment in what the Company anticipates may become a leading
industrial scale Canadian gummies manufacturer, Canopy Rivers believes it is
capitalizing on a significant opportunity in what is currently an underserved
and underdeveloped segment of the cannabis market. Once Dynaleo receives the
required licencing from Health Canada, it expects to begin operating its 27,000
sq. ft. purpose-built facility with the goal of producing enough gummies to
take a sizable bite out of the projected edibles market.
"We
believe that Dynaleo is positioned to become a market leader in cannabis
edibles manufacturing in Canada," said Narbé Alexandrian, President &
CEO, Canopy Rivers. "In the gummies market specifically, we see a
significant supply and demand imbalance and a move towards outsourcing products
to leading manufacturers. We think Dynaleo's manufacturing capabilities,
combined with its capable management team, position it to help close this
supply gap in the short term and become a trusted manufacturer of cannabis
edibles in the long term."
When
Cannabis 2.0 launched in Canada, regulatory uncertainties around the gummy
format led many license holders to focus on other edible cannabis formats, with
only some licensed producers investing in the infrastructure to produce
gummies. As a result of this, initial market observations suggest that the
demand for edibles is significantly ahead of supply, with limited product
availability and consistently high out-of-stock rates relative to other
products.
Headset
data from mature U.S. markets, combined with Deloitte's projection that
Canada's edibles market could be worth $1.6 billion annually, indicates that
there is an opportunity for increased gummy production in Canada. In Colorado
and California, Headset reports that gummies were the top selling edible
product, accounting for 55% and 56% of edible cannabis sales respectively in
2019. Assuming that Canadians emulate these consumption habits, Canadian
licensed producers may not yet have the production capacity or partnerships to
fulfill this demand.
"On
top of helping Canada's licensed producers close the supply gap, we also
believe that Dynaleo will play a role in expanding the total addressable market
for cannabis products, with market research indicating that new consumers are
more likely to enter the cannabis market through edibles than other
products," added Alexandrian.
Another
competitor looking to enter the EU marketplace, Aleafia Health Inc.’s (TSX:
ALEF)
(OTC:
ALEAF)
indirect subsidiary, Emblem Germany GmbH, recently
announced
formally submitting its application to German regulators for EU Good
Manufacturing Practices certification.
The
Company’s newly licensed Paris Facility has been purpose built to meet EU-GMP
certification requirements, pharmaceutical-grade production’s highest standard,
and as a result, provides wide access to global markets. The application, if
successful, would allow the Company’s Paris Facility to produce and export
EU-GMP certified cannabis products to the European Union.
Cannabis
production operations commenced on May 6, 2020 at the Paris Facility Phase II
expansion, only three business days following receipt of the amended Health
Canada license. Aleafia Health indirectly owns 60 percent of Emblem Germany, by
way of a joint-venture between Emblem and German pharmaceutical wholesaler and
logistics company, Acnos Pharma GmbH. It is difficult to ascertain the timeline
for securing certification, but the Company intends to continue preparing for
an eventual facility inspection.
Aleafia
Health and Acnos’ senior management are directing the effort and have
previously led the build-out, certification and operation of multiple EU-GMP
certified pharmaceutical production facilities in The Netherlands, Germany and
North America.
Later
this month, Acnos is expected to complete a new state-of-the-art pharmaceutical
production and supply chain facility in Aachen Brand, Germany. It contains a
dedicated cannabis distribution hub that Acnos owns and Emblem Germany will
operate, allowing the Company to commence sales upon receipt of necessary
German export and import permits.
“The
state-of-art expansion of the Paris Facility, purpose built to meet EU-GMP
standards, creates a unique competitive advantage with significant barriers to
entry,” said Aleafia Health CEO, Geoffrey Benic. “We look forward to leveraging
the skillsets of our strong partner Acnos Pharma along with our management
team’s in-house EU-GMP expertise.”
“The
near completion of our international cannabis distribution center along with
Emblem’s Paris Facility Phase II expansion licence are breakthrough milestones
toward our goal to achieve a EU-GMP Licence and receiving Emblem-produced
cannabis oil products in Germany," said Maximillian Claudel, Acnos
Co-Owner and Managing Director, Emblem Germany.
Hemp, Inc. (OTC:
HEMP),
a global leader in the industrial hemp industry with bi-coastal processing
centers, including the 85,000 square foot multipurpose industrial hemp
processing facility on 9 acres in Spring Hope, NC, a 55,000 square foot
state-of the art local processing center in White City, Oregon, a 500-acre hemp
growing Veteran Village Kins Community in Golden Valley, Arizona, two model
“Small Family Hemp Farms” in North Carolina and Arizona, a pre-roll blending
manufacturing facility in Las Vegas, NV, and a 5,000 square-foot retail store
in Kingman, Arizona, is also bringing new products to market having
announced the
launch of the King of Hemp™ website where Bruce Perlowin’s King of Hemp™
pre-rolls, made from premium, smokable hemp flower, are available for purchase.
Hemp,
Inc. CEO, Bruce Perlowin’s King of Hemp™ pre-roll line offers high-end products
that are an effective and flavorful, smokable alternative to cigarettes and
other hemp consumption methods. The newly launched King of Hemp™ pre-rolls are
compliant with the 2018 Farm Bill, federal regulations, and regulations in the
markets where they are available for purchase. The King of Hemp™ pre-rolls can
be purchased individually or in packs of 6. Each pre-roll is 1 gram and does
not exceed 0.3% THC.
King
of Hemp™ pre-rolls use A and B hemp colas which are derived from Pre-98 OG
Bubba Kush, one of the top selling cultivars on the market. The strain, rich
soil and climate lend themselves to these colas being among the highest quality
buds, positioning them to be some of the best tasting for consumption.
The
Company’s new website for its King of Hemp™ line (www.kingofhempusa.com) also has CBD oil
tinctures available for purchase. The tinctures are available in two flavors,
Natural and Peppermint, and contain full-spectrum hemp oil extracted from the
flowers and leaves of hemp plants sustainably sourced from Colorado. They are
also compliant with the regulations created by the Colorado Department of
Agriculture in regards to industrial hemp. The tinctures contain .3% or less
THC and are compliant with the 2018 Farm Bill.
“The
King of Hemp™ pre-rolls were well received during our soft launch and have been
lauded as one of the best smokes out there. We crafted them with great care --
from concept to the cola, and now with our official launch,” said Hemp, Inc.
CEO, Bruce Perlowin. “We really wanted to give this product line the time and
respect it needed to be brought to market. I’m very excited for hemp
enthusiasts, CBD patients and first-time hemp smokers to enjoy the King of
Hemp™ pre-roll line.”
As
the hemp/CBD and cannabis industry continues to see aggressive online sales and
demand in new international markets there will be significant opportunity for
great new product innovation. This is especially true as the industry continues
to remain dependent on online sales which forces businesses to be much more
aware of consumer feedback and product preferences.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure:
this news article featuring CSUI is a paid for article on Investorideas.com as
part of a monthly news and social media program. More disclaimer
info: https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and our other news services on
the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact
Investorideas.com
800
665 0411
